Reading Time: 3 minutes
Listen to this article
FDA Clears Vizz Eye Drops as New Vision Solution
Representational Image : Wikimedia Commons
FDA Clears Vizz Eye Drops as New Vision Solution
Representational Image : Wikimedia Commons

FDA Clears Vizz Eye Drops as New Vision Solution

The U.S. Food and Drug Administration (FDA) has approved Vizz eye drops, a new treatment for adults over 40 who struggle with near vision. Developed by Lenz Therapeutics, the drops improve near vision within minutes and may offer an alternative to reading glasses for millions of people.

How the Drops Work

Vizz eye drops use a medicine called aceclidine. The drops gently shrink the pupil, creating what’s known as a “pinhole effect.” Think of it like adjusting a camera lens; everything in the foreground suddenly becomes sharper. Unlike some older treatments, Vizz does not blur distance vision or cause the odd “zoomed-in” feeling.

Results from Clinical Trials

In clinical studies, the drops worked quickly and lasted for most of the day.

  • Clearer near vision started in about 30 minutes
  • The strongest results appeared around 3 hours
  • The benefits lasted up to 10 hours

About 7 in 10 participants could read three extra lines on a near-vision chart without glasses.

Possible Side Effects

Like any treatment, Vizz eye drops can cause mild side effects. Some people reported:

  • Temporary dim vision
  • Mild irritation
  • Headaches

Because vision may be blurry at first, the FDA advises patients not to drive or use heavy machinery until their sight clears. Extra care is also needed in low-light settings, such as nighttime driving.

A Shift in Eye Care

According to experts, this approval is a meaningful step forward. Dr. Marc Bloomenstein, an investigator in the trials, called Vizz “a welcome solution for patients and doctors.” He believes it could quickly become a standard option for treating presbyopia.

Prescription-Only Availability

Lenz Therapeutics confirmed that Vizz eye drops will be available only by prescription. For adults frustrated with age-related near vision changes, this new option may provide a much-needed sense of freedom, helping them enjoy daily tasks without always reaching for reading glasses.

Conclusion

The approval of Vizz eye drops offers adults over 40 a new way to manage presbyopia without always relying on reading glasses. With quick results, lasting benefits, and manageable side effects, this treatment could reshape how doctors and patients approach age-related near vision loss in everyday life.

SourceInputs from various media Sources 

Priya Bairagi

Reviewed by Dr Aarti Nehra (MBBS, MMST)

I’m a pharmacist with a strong background in health sciences. I hold a BSc from Delhi University and a pharmacy degree from PDM University. I write articles and daily health news while interviewing doctors to bring you the latest insights. In my free time, you’ll find me at the gym or lost in a sci-fi novel.

Scroll to Top